Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| D007410 | Intestinal Diseases NIH | 0.50 |
| D015212 | Inflammatory Bowel Diseases NIH | 0.33 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0002242 | Abnormal intestine morphology HPO | 0.50 |
| HP:0002037 | Inflammation of the large intestine HPO | 0.33 |
Navigate: Correlations HPO
There is one clinical trial.
This is a Phase 1, 2-part, open-label study. Part A will be a formulation bridging and food effect study in healthy adult subjects. Part B will be an assessment of pharmacokinetics (PK) in healthy adult Chinese subjects.
Description: Area under the concentration-time curve, from time 0 to the last observed non-zero concentration (AUC0-t) of TD-1473 in Plasma
Measure: AUC0-t Time: Predose and at prespecified time points up to 5 days after dosing on Day 1 of each periodDescription: Area under the concentration-time curve, from time 0 extrapolated to infinity (AUC0-inf) of TD-1473 in Plasma
Measure: AUC0-inf Time: Predose and at prespecified time points up to 5 days after dosing on Day 1 of each periodDescription: Maximum observed concentration (Cmax) of TD-1473 in Plasma
Measure: Cmax Time: Predose and at prespecified time points up to 5 days after dosing on Day 1 of each periodDescription: Number and severity of treatment emergent adverse events.
Measure: Adverse events Time: Day 1 through Day 7 of each periodAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports